Gene Therapy Regulation: A Necessary Hurdle
Executive Summary
Regulation of gene therapy is rightly more stringent than it is for other kinds of drug research. But some companies have found the UK system cumbersome, and are doing their research elsewhere.
You may also be interested in...
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”
The New Antibodies Revolutionizing Medicine
Nucleic acid-based therapies are poised to revolutionize medicine – just as antibodies did thirty years ago.
What Next In Oncology?
Oncology dominates pharma sales and pipeline league tables. But where is the next Keytruda?